Login / Signup

Late Relapse in Genetically Determined Infantile Myofibromatosis. A Case Report and Brief Focus on Recurrences.

Alessio ConteDamiana De PadovaSerena GiglioVirginia LivellaraCarla ManzittiPatrizia De MarcoValeria CapraStefania Sorrentino
Published in: Journal of pediatric hematology/oncology (2024)
In association with initial treatment, genetic testing is crucial for tailored clinical practice and follow-up in patients diagnosed with IM.
Keyphrases
  • end stage renal disease
  • clinical practice
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • patient reported outcomes
  • patient reported